No major surprise in the H1 21 numbers

29/07/21 -"Air Liquide saw a rebound of the industrial activities in Q2, while Electronics and Healthcare remained at a high level Geographically, all regions benefited Efficiencies (understand cost-cutting) ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

29/07/21

Download

You may also be interested by these reports :

22/04/24

Brenntag

Downgrade to Add – New target price EUR 85

19/04/24

Gurit

Disappointing on first sight, but well in-line with our investment case on second glance

16/04/24

Clariant

Supporting fundamentals & no more Kottmann items

11/04/24

Givaudan

Strong 1Q growth helped by high(er) FX pricing, especially in LatAm

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue